137 related articles for article (PubMed ID: 38169111)
1. Further evidence that the neurodevelopmental gene FBXW7 predisposes to Wilms tumor.
Meier-Abt F; Kraemer D; Braun N; Reinehr M; Stutz-Grunder E; Steindl K; Rauch A
Am J Med Genet A; 2024 Jun; 194(6):e63528. PubMed ID: 38169111
[TBL] [Abstract][Full Text] [Related]
2. Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome.
Stephenson SEM; Costain G; Blok LER; Silk MA; Nguyen TB; Dong X; Alhuzaimi DE; Dowling JJ; Walker S; Amburgey K; Hayeems RZ; Rodan LH; Schwartz MA; Picker J; Lynch SA; Gupta A; Rasmussen KJ; Schimmenti LA; Klee EW; Niu Z; Agre KE; Chilton I; Chung WK; Revah-Politi A; Au PYB; Griffith C; Racobaldo M; Raas-Rothschild A; Ben Zeev B; Barel O; Moutton S; Morice-Picard F; Carmignac V; Cornaton J; Marle N; Devinsky O; Stimach C; Wechsler SB; Hainline BE; Sapp K; Willems M; Bruel AL; Dias KR; Evans CA; Roscioli T; Sachdev R; Temple SEL; Zhu Y; Baker JJ; Scheffer IE; Gardiner FJ; Schneider AL; Muir AM; Mefford HC; Crunk A; Heise EM; Millan F; Monaghan KG; Person R; Rhodes L; Richards S; Wentzensen IM; Cogné B; Isidor B; Nizon M; Vincent M; Besnard T; Piton A; Marcelis C; Kato K; Koyama N; Ogi T; Goh ES; Richmond C; Amor DJ; Boyce JO; Morgan AT; Hildebrand MS; Kaspi A; Bahlo M; Friðriksdóttir R; Katrínardóttir H; Sulem P; Stefánsson K; Björnsson HT; Mandelstam S; Morleo M; Mariani M; ; Scala M; Accogli A; Torella A; Capra V; Wallis M; Jansen S; Weisfisz Q; de Haan H; Sadedin S; ; Lim SC; White SM; Ascher DB; Schenck A; Lockhart PJ; Christodoulou J; Tan TY
Am J Hum Genet; 2022 Apr; 109(4):601-617. PubMed ID: 35395208
[TBL] [Abstract][Full Text] [Related]
3. Identification of new Wilms tumour predisposition genes: an exome sequencing study.
Mahamdallie S; Yost S; Poyastro-Pearson E; Holt E; Zachariou A; Seal S; Elliott A; Clarke M; Warren-Perry M; Hanks S; Anderson J; Bomken S; Cole T; Farah R; Furtwaengler R; Glaser A; Grundy R; Hayden J; Lowis S; Millot F; Nicholson J; Ronghe M; Skeen J; Williams D; Yeomanson D; Ruark E; Rahman N
Lancet Child Adolesc Health; 2019 May; 3(5):322-331. PubMed ID: 30885698
[TBL] [Abstract][Full Text] [Related]
4. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.
Williams RD; Al-Saadi R; Chagtai T; Popov S; Messahel B; Sebire N; Gessler M; Wegert J; Graf N; Leuschner I; Hubank M; Jones C; Vujanic G; Pritchard-Jones K; ;
Clin Cancer Res; 2010 Apr; 16(7):2036-45. PubMed ID: 20332316
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
Hol JA; Kuiper RP; van Dijk F; Waanders E; van Peer SE; Koudijs MJ; Bladergroen R; van Reijmersdal SV; Morgado LM; Bliek J; Lombardi MP; Hopman S; Drost J; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MCJ
J Clin Oncol; 2022 Jun; 40(17):1892-1902. PubMed ID: 35230882
[TBL] [Abstract][Full Text] [Related]
6. Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort.
Stoltze UK; Hildonen M; Hansen TVO; Foss-Skiftesvik J; Byrjalsen A; Lundsgaard M; Pignata L; Grønskov K; Tumer Z; Schmiegelow K; Brok JS; Wadt KAW
J Med Genet; 2023 Sep; 60(9):842-849. PubMed ID: 37019617
[TBL] [Abstract][Full Text] [Related]
7. TRIM28 haploinsufficiency predisposes to Wilms tumor.
Diets IJ; Hoyer J; Ekici AB; Popp B; Hoogerbrugge N; van Reijmersdal SV; Bhaskaran R; Hadjihannas M; Vasileiou G; Thiel CT; Seven D; Uebe S; Ilencikova D; Waanders E; Mavinkurve-Groothuis AMC; Roeleveld N; de Krijger RR; Wegert J; Graf N; Vokuhl C; Agaimy A; Gessler M; Reis A; Kuiper RP; Jongmans MCJ; Metzler M
Int J Cancer; 2019 Aug; 145(4):941-951. PubMed ID: 30694527
[TBL] [Abstract][Full Text] [Related]
8. 11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.
Fiala EM; Ortiz MV; Kennedy JA; Glodzik D; Fleischut MH; Duffy KA; Hathaway ER; Heaton T; Gerstle JT; Steinherz P; Shukla N; McNeer N; Tkachuk K; Bouvier N; Cadoo K; Carlo MI; Latham A; Dubard Gault M; Joseph V; Kemel Y; Kentsis A; Stadler Z; La Quaglia M; Papaemmanuil E; Friedman D; Ganguly A; Kung A; Offit K; Kalish JM; Walsh MF
Cancer; 2020 Jul; 126(13):3114-3121. PubMed ID: 32320050
[TBL] [Abstract][Full Text] [Related]
9. Wilms tumour resulting from paternal transmission of a TRIM28 pathogenic variant-A first report.
Whitworth J; Armstrong R; Maher ER
Eur J Hum Genet; 2024 Mar; 32(3):361-364. PubMed ID: 38282073
[TBL] [Abstract][Full Text] [Related]
10. Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant.
Falcone MP; Pritchard-Jones K; Brok J; Mifsud W; Williams RD; Nakata K; Tugnait S; Al-Saadi R; Side L; Anderson J; Duncan C; Marks SD; Bockenhauer D; Chowdhury T
Pediatr Nephrol; 2022 Apr; 37(4):821-832. PubMed ID: 34608521
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.
Halliday BJ; Fukuzawa R; Markie DM; Grundy RG; Ludgate JL; Black MA; Skeen JE; Weeks RJ; Catchpoole DR; Roberts AGK; Reeve AE; Morison IM
PLoS Genet; 2018 Jun; 14(6):e1007399. PubMed ID: 29912901
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel CTR9 germline mutation in a family with Wilms tumor.
Martins AG; Pinto AT; Domingues R; Cavaco BM
Eur J Med Genet; 2018 May; 61(5):294-299. PubMed ID: 29292210
[TBL] [Abstract][Full Text] [Related]
13. WT1 gene analysis in sporadic early-onset and bilateral wilms tumor patients without associated abnormalities.
Perotti D; Mondini P; Terenziani M; Spreafico F; Collini P; Fossati-Bellani F; Radice P
J Pediatr Hematol Oncol; 2005 Apr; 27(4):197-201. PubMed ID: 15838390
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of Xp22.11 Duplication as a Germline Susceptibility Alteration in a Wilms Tumor Arising in Horseshoe Kidney.
Zhou HF; Amarillo IE; Snyder S; Granadillo JL; O'Conor CJ; Dillon P; Wilson D; Huang FS; Dehner LP; He M
Fetal Pediatr Pathol; 2022 Aug; 41(4):682-688. PubMed ID: 33960268
[No Abstract] [Full Text] [Related]
15. Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients.
Segers H; Kersseboom R; Alders M; Pieters R; Wagner A; van den Heuvel-Eibrink MM
Eur J Cancer; 2012 Nov; 48(17):3249-56. PubMed ID: 22796116
[TBL] [Abstract][Full Text] [Related]
16. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
[TBL] [Abstract][Full Text] [Related]
17. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene.
Slade I; Stephens P; Douglas J; Barker K; Stebbings L; Abbaszadeh F; Pritchard-Jones K; ; Cole R; Pizer B; Stiller C; Vujanic G; Scott RH; Stratton MR; Rahman N
J Med Genet; 2010 May; 47(5):342-7. PubMed ID: 19948536
[TBL] [Abstract][Full Text] [Related]
18. TRIM28 variants and Wilms' tumour predisposition.
Hol JA; Diets IJ; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MC; Kuiper RP
J Pathol; 2021 Jul; 254(4):494-504. PubMed ID: 33565090
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
Escobar D; Bushara O; Sun L; Liao J; Yang GY
Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
[TBL] [Abstract][Full Text] [Related]
20. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
